| Name | Title | Contact Details |
|---|---|---|
Howard Law |
General Counsel (U.S.) | Profile |
ClearView Healthcare Partners is a global strategy consulting firm focused on the life sciences sector. Founded in 2007 in Boston, the company provides strategic advice across various therapeutic areas and technologies. ClearView combines scientific expertise with analytical rigor to help clients develop growth strategies at the product, franchise, and corporate levels. The firm operates globally, with offices in North America, including Boston, New York, and San Francisco, and has expanded into Europe with locations in London and Zurich. ClearView offers a range of services, including market analysis, launch strategy development, pricing strategies, and advanced analytics, tailored to support pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as investors in the life sciences sector. ClearView is guided by principles of clarity, quality, and collaboration, ensuring high-quality solutions developed in partnership with clients. The company fosters an intellectually stimulating environment and attracts motivated individuals through a competitive hiring process.
Mechanics is a Ohio-based community bank that offers services including personal and business banking, trust, mortgages and loans for individuals and businesses.
Search Discovery is a data strategy and activation company whose focus is helping you turn raw data into the right decisions. You get a smarter, more personalized approach across strategy, technology, and execution. Many companies like yours have been playing a guessing game when it comes to critical business decisions. Too often, you either dont know if you have the right data, dont know if you can trust it, or dont know exactly what to do with it. Its time to own the unknown, and only Search Discovery brings you this level of practical strategy, flexibility, and focus. Its also why so many of the worlds leading brands rely on us. And its how weve earned a client retention rate of over 90%. Search Discovery. Own the unknown.™ Search Discovery | Own the Unknown
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.